Financial Survey: Stericycle (SRCL) vs. Its Competitors
Stericycle (NASDAQ: SRCL) is one of 20 public companies in the “Waste Management, Disposal & Recycling Services” industry, but how does it weigh in compared to its rivals? We will compare Stericycle to related companies based on the strength of its dividends, valuation, risk, institutional ownership, analyst recommendations, profitability and earnings.
Volatility and Risk
Stericycle has a beta of 0.16, suggesting that its stock price is 84% less volatile than the S&P 500. Comparatively, Stericycle’s rivals have a beta of 0.62, suggesting that their average stock price is 38% less volatile than the S&P 500.
This table compares Stericycle and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Insider and Institutional Ownership
94.6% of Stericycle shares are owned by institutional investors. Comparatively, 53.0% of shares of all “Waste Management, Disposal & Recycling Services” companies are owned by institutional investors. 3.5% of Stericycle shares are owned by insiders. Comparatively, 12.3% of shares of all “Waste Management, Disposal & Recycling Services” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
This is a breakdown of current ratings and recommmendations for Stericycle and its rivals, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Stericycle presently has a consensus price target of $75.90, indicating a potential upside of 15.38%. As a group, “Waste Management, Disposal & Recycling Services” companies have a potential upside of 9.79%. Given Stericycle’s higher possible upside, research analysts clearly believe Stericycle is more favorable than its rivals.
Valuation and Earnings
This table compares Stericycle and its rivals revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Stericycle||$3.56 billion||$206.35 million||-115.40|
|Stericycle Competitors||$850.65 million||$28.19 million||149.04|
Stericycle has higher revenue and earnings than its rivals. Stericycle is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
Stericycle beats its rivals on 7 of the 13 factors compared.
Stericycle Company Profile
Stericycle, Inc. is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other. The Domestic and Canada RCS and International RCS segments include medical waste disposal, pharmaceutical waste disposal, hazardous waste management, sustainability solutions for expired or unused inventory, secure information destruction of documents and e-media, training and consulting through its Steri-Safe and Clinical Services programs, and other regulatory compliance services. The Domestic CRS segment consists of inbound/outbound communication, automated patient reminders, online scheduling, notifications, product retrievals, product returns and quality audits.
Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.